Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
890 studies found for:    nicotinamide
Show Display Options
Rank Status Study
1 Terminated Nicotinamide Versus Sevelamer Hydrochloride on Phosphatemia Control on Chronic Hemodialysed Patients
Conditions: Chronic Renal Failure;   Hemodialysis
Interventions: Drug: nicotinamide;   Drug: sevelamer;   Drug: cinacalcet
2 Completed "Pharmacokinetic Study of Nicotinamide Riboside"
Condition: Metabolic Disturbance
Intervention: Dietary Supplement: nicotinamide riboside
3 Completed Nicotinamide Safety Study
Conditions: Pregnancy Induced Hypertension;   Superimposed Preeclampsia;   Hypertension
Intervention: Drug: Nicotinamide
4 Active, not recruiting Niacin on Immune Activation : a Proof-of-concept Study
Condition: HIV
Intervention: Drug: Niacin
5 Completed Biosynthesis of PGD2 in Vivo
Condition: Healthy Volunteer
Interventions: Dietary Supplement: 5 days of placebo followed by 600mg niacin;   Dietary Supplement: aspirin first;   Drug: 81 mg Aspirin;   Dietary Supplement: Niaspan;   Drug: Celebrex and niacin
6 Recruiting Anticancer Activity of Nicotinamide on Lung Cancer
Condition: Non-Small-Cell Lung Carcinoma
Intervention: Drug: Nicotinamide
7 Completed Short-term Effect of Extended-release Niacin on Endothelial Function.
Condition: Hypoalphalipoproteinemia
Intervention: Drug: Niacin
8 Completed Assessment of Interaction Between Vytorin and Niaspan in Healthy Subjects (P04955AM2)
Conditions: Hypercholesterolemia;   Hyperlipidemia
Interventions: Drug: Vytorin + Niaspan;   Drug: Vytorin;   Drug: Niaspan
9 Recruiting The COMBINE Study: The CKD Optimal Management With BInders and NicotinamidE
Condition: Chronic Kidney Disease
Interventions: Drug: Nicotinamide;   Drug: Lanthanum Carbonate;   Drug: Placebo (for Nicotinamide);   Drug: Placebo (for lanthanum carbonate)
10 Completed
Has Results
Effect of Niacin on Transport of HDL and Relationship to Atherogenic Lipoproteins and Lipolysis
Condition: Dyslipidemias
Interventions: Drug: Niacin;   Other: Placebo
11 Not yet recruiting Nicotinamide Riboside and Metabolic Health
Conditions: Obesity;   Insulin Resistance
Interventions: Dietary Supplement: Nicotinamide Riboside (Niagen);   Dietary Supplement: Placebo
12 Recruiting Pilot Study of Niacinamide in Polycystic Kidney Disease (NIAC-PKD2)
Condition: Polycystic Kidney Disease
Interventions: Dietary Supplement: Niacinamide;   Other: Placebo
13 Active, not recruiting Safety & Efficacy of Nicotinamide Riboside Supplementation for Improving Physiological Function in Middle-Aged and Older Adults
Condition: Aging
Interventions: Dietary Supplement: Niagen™;   Dietary Supplement: Placebo
14 Completed Nicotinamide in the Treatment of Psoriasis
Condition: Psoriasis
Interventions: Drug: Calcipotriol plus Nicotinamide;   Drug: Calcipotriol
15 Completed Niacin, N-3 Fatty Acids and Insulin Resistance
Conditions: Metabolic Syndrome;   Hypertriglyceridemia
Interventions: Drug: omega-3 acid ethyl esters;   Drug: extended release niacin;   Drug: placebo;   Drug: combined treatment
16 Completed
Has Results
Phase I Vorinostat in Combination With Niacinamide and Etoposide for Lymphoid Malignancies
Conditions: Hodgkin's Disease;   Non-Hodgkin's Lymphoma
Interventions: Drug: Vorinostat;   Drug: Niacinamide;   Drug: Etoposide
17 Recruiting Effects of Niacin On Fatty Acid Trapping
Condition: Dyslipidemia
Interventions: Drug: ER Niacin Oral Fat Challenge;   Drug: IR Niacin Oral Fat Challenge;   Other: Placebo Oral Fat Challenge
18 Completed Comparison of TRIA-662 500 mg and Niaspan 1000 mg in Healthy Male and Female Volunteers Under Fed Conditions
Condition: Healthy
Interventions: Drug: Niaspan;   Drug: TRIA-662
19 Recruiting Nicotinic Acid in Hemodialysis Patients With Hyperphosphatemia
Condition: Hyperphosphatemia
Interventions: Drug: Nicotinic Acids;   Drug: Calcium Carbonate
20 Completed Pharmacokinetic Analysis of Nicotinamide Riboside
Condition: Healthy Participants
Intervention: Dietary Supplement: Nicotinamide riboside

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years